Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > E-cadherin expression in canine malignant mammary tumours: Relationship to other clinico-pathological variables
Publication

Publications

E-cadherin expression in canine malignant mammary tumours: Relationship to other clinico-pathological variables

Title
E-cadherin expression in canine malignant mammary tumours: Relationship to other clinico-pathological variables
Type
Article in International Scientific Journal
Year
2006
Authors
Augusto Matos
(Author)
ICBAS
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page Without ORCID
Lopes, C
(Author)
ICBAS
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page Without ORCID
carvalheira, j
(Author)
ICBAS
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Santos, M
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Rutteman, GR
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Fátima Gärtner
(Author)
ICBAS
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Journal
Vol. 134
Pages: 182-189
ISSN: 0021-9975
Publisher: Elsevier
Other information
Authenticus ID: P-004-NFS
Abstract (EN): The relationship between E-cadherin epithelial expression, as detected by immunohistochemical methods, and other clinico-pathological characteristics of canine malignant mammary tumours was studied in 77 tumours surgically removed from 45 female dogs. The immunohistochemical assessment was based on the estimated percentage of epithelial cells with membranous labelling. Reduction Of E-cadherin expression was significantly related to size and ulceration of tumours but not to fixation to skin or underlying tissue; it was also related to lymph node metastasis, necrosis and infiltrative growth. Histological type (but not histological grade) was related to E-cadherin expression, with solid tumours more frequently lacking expression and tubulopapillary tumours showing increased expression as compared with the Other types. The significant relationship between E-cadherin and other known factors of poor prognosis suggests that the loss of E-cadherin expression may have prognostic value in canine malignant mammary tumours.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 8
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

Canine Gastric Pathology: A Review (2016)
Another Publication in an International Scientific Journal
Amorim, I; Taulescu, MA; Day, MJ; Catoi, C; Celso Reis; Carneiro F; Gaertner, F
Solid Carcinoma of the Canine Mammary Gland: a Histological Type or Tumour Cell Arrangement? (2022)
Article in International Scientific Journal
Nakagaki, KY; Nunes, MM; Garcia, APV; Nunes, FC; Fernando Schmitt; Cassali, GD
Single Nucleotide Polymorphisms Influence Histological Type and Grade of Canine Malignant Mammary Tumours (2019)
Article in International Scientific Journal
Canadas Sousa, A; Santos, M; Rui Medeiros; Dias Pereira, P
Reduced expression of claudin-2 is associated with high histological grade and metastasis of feline mammary carcinomas. (2014)
Article in International Scientific Journal
Dias Pereira P; Rema A; Carvalho F; Augusto Faustino; Flores AR

See all (20)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-19 at 00:58:11 | Privacy Policy | Personal Data Protection Policy | Whistleblowing